Originally developed for type 2 diabetes, these medications have shown remarkable efficacy in promoting substantial weight loss and even cardiovascular benefits, leading to widespread use
Three Pivotal Points to Remember: Semaglutide shows promise for significant weight loss, but long-term studies are necessary
Mohamed Hasan and my lovely wife Saja Mousa, their dedication and overwhelming attitude toward helping me is responsible for completing the chapter
PlexusDx supports precision-wellness conversations with providers by offering genetic context and baseline assessment tools that can inform dosing decisions
(): 18 HHT patients treated with direct PuraBond application to nasal telangiectasias Improved Epistaxis Severity Scores No adverse events, allergic reactions, or pain reported Less crusting and healthier-appearing mucosa at follow-up (): 985 patients undergoing turbinate reduction, with or without PuraBond Crusting reduced Mucosal re-epithelialisation observed Reliable haemostasis and reduced post-op bleed rates No product-related complications Rather than replacing existing methods, PuraBond is being integrated into ENT practice to help support haemostasis, protect fragile mucosa, and reduce procedural trauma, especially in patients with underlying vascular fragility like HHT